Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients

被引：30
作者：
Campo, RE [1 ]
Lalanne, R
Tanner, TJ
Jayaweera, DT
Rodriguez, AE
Fontaine, L
Kolber, MA
机构：
[1] Univ Miami, Sch Med, Div Infect Dis, Miami, FL USA
[2] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
AIDS | 2005年 / 19卷 / 04期
关键词：
D O I：
10.1097/01.aids.0000161777.38438.ed
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：447 / 449
页数：3
相关论文
共 15 条
  • [1] ARRIBAS JR, 2004, 15 INT AIDS C BANGK
  • [2] Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients
    Benson, CA
    Deeks, SG
    Brun, SC
    Gulick, RM
    Eron, JJ
    Kessler, HA
    Murphy, RL
    Hicks, C
    King, M
    Wheeler, D
    Feinberg, J
    Stryker, R
    Sax, PE
    Riddler, S
    Thompson, M
    Real, K
    Hsu, A
    Kempf, D
    Japour, AJ
    Sun, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (05) : 599 - 607
  • [3] Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy
    Condra, JH
    Petropoulos, CJ
    Ziermann, R
    Schleif, WA
    Shivaprakash, M
    Emini, EA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) : 758 - 765
  • [4] Guidelines for using antiretroviral agents among HIV-infected adults and adolescents - The panel on clinical practices for treatment of HIV
    Dybul, M
    Fauci, AS
    Bartlett, JG
    Kaplan, JE
    Pau, AK
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 137 (05) : 381 - 433
  • [5] Final analysis of the Trilege induction-maintenance trial: results at 18 months
    Flandre, P
    Raffi, F
    Descamps, D
    Calvez, V
    Peytavin, G
    Meiffredy, V
    Harel, M
    Hazebrouck, S
    Pialoux, G
    Aboulker, JP
    Vezinet, FB
    [J]. AIDS, 2002, 16 (04) : 561 - 568
  • [6] GATHE JC, 2004, 15 INT AIDS C BANGK
  • [7] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
    Gulick, RM
    Mellors, JW
    Havlir, D
    Eron, JJ
    Gonzalez, C
    McMahon, D
    Richman, DD
    Valentine, FT
    Jonas, L
    Meibohm, A
    Emini, EA
    Chodakewitz, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 734 - 739
  • [8] Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
    Havlir, DV
    Marschner, IC
    Hirsch, MS
    Collier, AC
    Tebas, P
    Bassett, RL
    Ioannidis, JPA
    Holohan, MK
    Leavitt, R
    Boone, G
    Richman, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (18) : 1261 - 1268
  • [9] Ritonavir boosted indinavir treatment as a simplified maintenance 'mono'-therapy for HIV infection
    Kahlert, C
    Hupfer, M
    Wagels, T
    Bueche, D
    Fierz, W
    Walker, UA
    Vernazza, PL
    [J]. AIDS, 2004, 18 (06) : 955 - 957
  • [10] Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients
    Kempf, DJ
    Isaacson, JD
    King, MS
    Brun, SC
    Xu, Y
    Real, K
    Bernstein, BM
    Japour, AJ
    Sun, E
    Rode, RA
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (16) : 7462 - 7469
12